dapsone has been researched along with Leprosy, Cutaneous in 128 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " CASE REPORT A 22-year-old woman, who was diagnosed with multibacillary leprosy, developed dapsone-induced methemoglobinemia and hemolytic anemia, complicated by melioidosis." | 8.02 | Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction. ( Chew, LP; Chua, HH; Fam, TL; Lee, JTH; Muniandy, P; Tang, ASO; Ting, IPL; Wong, QY; Yeo, ST, 2021) |
| "In Paraguay, the National Leprosy/Tuberculosis Program is based on a combined chemotherapy with isoprodian and rifampicin." | 7.67 | Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients. ( Alvarenga, AE; Haubitz, I; Leguizamon, O; Pritze, S, 1989) |
| "Dapsone is a drug of choice in the treatment of leprosy." | 5.30 | Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report. ( Arunthathi, S; Raju, S, 1998) |
| " The patient responded well to fluoroquinolone, rifampicin and clofazimine, with however, the occurrence of erythema nodosum leprosum." | 4.82 | [Histoid leprosy with erythema nodosum leprosum]. ( Alioua, Z; Benomar, S; Boudi, O; Bouzidi, A; Elhaouri, M; Ghfir, M; Sbai, M; Sedrati, OL, 2003) |
| " CASE REPORT A 22-year-old woman, who was diagnosed with multibacillary leprosy, developed dapsone-induced methemoglobinemia and hemolytic anemia, complicated by melioidosis." | 4.02 | Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction. ( Chew, LP; Chua, HH; Fam, TL; Lee, JTH; Muniandy, P; Tang, ASO; Ting, IPL; Wong, QY; Yeo, ST, 2021) |
| "Dapsone hypersensitivity syndrome (DHS) can be classified as a 'drug reaction with eosinophilia and systemic symptoms' (DRESS)." | 3.81 | Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report. ( Chellini, PR; Gavilanes, MC; Nery, JA; Palacio, AL; Rego, JG, 2015) |
| "Changes in hemoglobin (HGB) and serum albumin (SA) concentration associated with the onset of symptomatic erythema nodosum leprosum (ENL) were studied by comparing the values obtained on the day thalidomide or prednisone therapy commenced, with each patients' preceding values." | 3.71 | Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy. ( Rea, TH, 2001) |
| "Between 1986 and 1989, in 5 departments of Senegal, 436 new cases of leprosy were detected, of whom 225 were put under dapsone monotherapy and 211 under multidrug therapy (MDT)." | 3.69 | [The frequency of the appearance of perforating foot ulcers in patients with Hansen's disease as a function of treatment with disulone alone or with polychemotherapy]. ( Cartel, JL; Grauwin, MY; Mane, I, 1995) |
| "The feasibility and effects of a 3-year treatment using rifampicin (RFP), clofazimine (B663) and dapsone (DDS) in multibacillary leprosy patients in Yangzhou Prefecture and Dongtai County (1983-1986) are reported." | 3.68 | Effect of three-year multidrug therapy in multibacillary leprosy patients. ( Ji, F; Li, W; Luo, J; Tao, M; Wang, C; Yang, Z; Ye, G, 1990) |
| "In Paraguay, the National Leprosy/Tuberculosis Program is based on a combined chemotherapy with isoprodian and rifampicin." | 3.67 | Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients. ( Alvarenga, AE; Haubitz, I; Leguizamon, O; Pritze, S, 1989) |
| "This study sought to verify the correlation between leprosy types and the adverse effects of treatment drugs." | 2.77 | Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects. ( Almeida, PC; Bührer-Sékula, S; Cruz, R; Gonçalves, Hde S; Moraes, ME; Penna, GO; Pontes, MA, 2012) |
| "No confirmed relapse has been observed within a follow-up period of 6 months to 7 years and 3 months [59 person-years at risk (PYR)] for TT/BT patients and of 4 months to 5 years and 10 months (100 PYR) for BB/BL/LL patients." | 2.68 | Daily multidrug therapy for leprosy; results of a fourteen-year experience. ( Cottenot, F; de Carsalade, GY; Flageul, B; Pennec, J; Spindler, E; Wallach, D, 1997) |
| "No further relapse has been diagnosed since the beginning of retreatment." | 2.68 | High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks. ( Grosset, JH; Jamet, P; Ji, B; Perani, EG; Sow, S; Traore, I, 1997) |
| " Its optimal dosage appears to be 400 mg daily, and combination with dapsone and clofazimine does not enhance its activity." | 2.67 | Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy. ( Grosset, JH; Ji, B; N'Deli, L; Perani, EG; Petinom, C, 1994) |
| "Dapsone is an efficient anti-inflammatory and antimycobacterial agent." | 2.44 | Dapsone-induced photosensitivity: a rare clinical presentation. ( Kar, BR, 2008) |
| "Current treatment of leprosy involves use of 3 drugs: rifampicin (rifampin); clofazimine; and dapsone." | 2.41 | Leprosy. Recognition and treatment. ( Ramos-e-Silva, M; Rebello, PF, 2001) |
| "Leprosy is a socially stigmatized granulomatous skin disease caused by Mycobacterium leprae." | 1.62 | The Clinical Trend of Leprosy from 2000 to 2016 in Kaohsiung, a Major International Harbor City in Taiwan, Where Leprosy is Almost Eradicated. ( Huang, HW; Lee, CH; Lin, SH, 2021) |
| "Relapses are an indicator of MDT effectiveness and can reflect Mycobacterium leprae persistence or re-infection." | 1.62 | Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center. ( Hacker, MAVB; Illarramendi, X; Maia, RC; Moraes, MO; Nery, JAC; Sales, AM; Sarno, EN, 2021) |
| "Dapsone has been the mainstay for the treatment of leprosy since its discovery in the 1940s." | 1.56 | Hematological alterations in lepromatous leprosy: A cross-sectional observational study. ( Awan, KH; Chaudhary, M; Gupta, B; Gupta, S; Patil, S; Raj, AT, 2020) |
| "Lepromatous leprosy is associated with a high bacillary load and poor cellular immune response." | 1.56 | Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment. ( Bidari-Zerehpoosh, F; Bizaval, Z; Mozafari, N; Niknejad, N; Robati, RM, 2020) |
| "The swollen hands syndrome is probably due to chronic Mycobacterium leprae tenosynovitis." | 1.35 | [Lepromatous leprosy revealed by a swollen hands syndrome]. ( Boyé, T; Carli, P; Carsuzaa, F; Graffin, B; Landais, C; Leyral, G, 2009) |
| "Out of 34 leprosy patients undergoing treatment, 4 lepromatous leprosy patients were antibody positive, and 6." | 1.32 | Active surveillance of leprosy contacts in country with low prevalence rate. ( Abbasi, MA; Fukutomi, Y; Kai, M; Kashiwabara, Y; Khan, MZ; Kobayashi, K; Maeda, S; Maeda, Y; Makino, M; Shah, PA, 2004) |
| "Leprosy and vitiligo are common affections in the West Indies." | 1.31 | High prevalence of vitiligo in lepromatous leprosy. ( Boisseau-Garsaud, AM; Garsaud, P; Helenon, R; Quist, D; Saint-Cyr, I; Vezon, G, 2000) |
| "Dapsone is a drug of choice in the treatment of leprosy." | 1.30 | Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report. ( Arunthathi, S; Raju, S, 1998) |
| "Atracurium was given to facilitate tracheal intubation." | 1.30 | Anaesthetic considerations in a patient with lepromatous leprosy. ( Gombar, KK; Gombar, S; Mitra, S, 1998) |
| "Dapsone treated group showed a disability rate of 63." | 1.28 | Pattern of leprosy disabilities in Gorakhpur (Uttar Pradesh). ( Arora, SK; Girdhar, M; Mohan, L; Mukhija, RD, 1989) |
| "12 untreated lepromatous leprosy patients were screened for primary dapsone resistance by the uptake of labelled thymidine by macrophage resident M." | 1.28 | Primary dapsone resistance as assessed by uptake of labelled thymidine by the macrophage resident Mycobacterium leprae. ( Ganguly, NK; Kaur, S; Kumar, B; Thakur, M; Vaishnavi, C, 1989) |
| " It is suggested that dapsone dosage be regulated to body weight and preferably not to exceed 1." | 1.28 | Investigations into the haemolytic effects of dapsone therapy in leprosy patients. ( Balakrishnan, S; Karthikeyan, S; Ramu, G, 1989) |
| "Tetanus in lepromatous leprosy is rare and reported occasionally as case reports only." | 1.27 | Tetanus in patient with lepromatous leprosy (I). ( Anilkumar, G; Nampalle, VB; Nathani, PJ; Sonvane, MV, 1988) |
| "Dapsone (DDS) is a drug of choice in the treatment of leprosy." | 1.27 | Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients. ( Bakaya, V; Garg, SK; Kaur, S; Kumar, B; Lal, R; Shukla, VK, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (22.66) | 18.7374 |
| 1990's | 47 (36.72) | 18.2507 |
| 2000's | 25 (19.53) | 29.6817 |
| 2010's | 21 (16.41) | 24.3611 |
| 2020's | 6 (4.69) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, B | 1 |
| Gupta, S | 1 |
| Chaudhary, M | 1 |
| Raj, AT | 1 |
| Awan, KH | 1 |
| Patil, S | 1 |
| Duran Merino, CE | 1 |
| Ortiz Úsuga, MC | 1 |
| Jaramillo, MJ | 1 |
| Rodríguez, AM | 1 |
| Huang, HW | 1 |
| Lee, CH | 1 |
| Lin, SH | 1 |
| Robati, RM | 1 |
| Mozafari, N | 1 |
| Bidari-Zerehpoosh, F | 1 |
| Niknejad, N | 1 |
| Bizaval, Z | 1 |
| Nery, JAC | 1 |
| Sales, AM | 1 |
| Hacker, MAVB | 1 |
| Moraes, MO | 1 |
| Maia, RC | 1 |
| Sarno, EN | 3 |
| Illarramendi, X | 1 |
| Tang, ASO | 1 |
| Wong, QY | 1 |
| Yeo, ST | 1 |
| Ting, IPL | 1 |
| Lee, JTH | 1 |
| Fam, TL | 1 |
| Chew, LP | 1 |
| Chua, HH | 1 |
| Muniandy, P | 1 |
| Fischer, M | 1 |
| Müller, A | 1 |
| Wolfsperger, F | 1 |
| Kofler, L | 1 |
| Yazdi, AS | 1 |
| Tavares Rodrigues, F | 1 |
| Pereira Cardozo, MR | 1 |
| da Costa Nery, JA | 1 |
| Tirhazouine, I | 1 |
| Chiheb, S | 1 |
| Hali, F | 1 |
| Rifki, A | 1 |
| Benchikhi, H | 1 |
| Yang, S | 1 |
| Makredes, M | 1 |
| O'Donnell, P | 1 |
| Levin, NA | 1 |
| Gimovsky, AC | 1 |
| Macri, CJ | 1 |
| Markova, A | 1 |
| Duquesnoy, R | 1 |
| Levis, W | 1 |
| El Morabite, K | 1 |
| Tbatou, F | 1 |
| Ait Ourhroui, M | 1 |
| Senouci, K | 1 |
| Hassam, B | 1 |
| Mirfazaelian, H | 1 |
| Eilami, O | 1 |
| Afzalimoghadam, M | 1 |
| Daneshbod, Y | 1 |
| Fu, X | 1 |
| Liu, H | 1 |
| Zhang, F | 1 |
| Han, XY | 1 |
| Quintanilla, M | 1 |
| Gavilanes, MC | 1 |
| Palacio, AL | 1 |
| Chellini, PR | 1 |
| Nery, JA | 1 |
| Rego, JG | 1 |
| Kim, JS | 1 |
| Kwon, SH | 1 |
| Shin, JY | 1 |
| Coelho de Sousa, V | 1 |
| Laureano, A | 1 |
| Cardoso, J | 1 |
| Ozturk, Z | 1 |
| Tatliparmak, A | 1 |
| Kar, BR | 1 |
| Landais, C | 1 |
| Graffin, B | 1 |
| Leyral, G | 1 |
| Boyé, T | 1 |
| Carli, P | 1 |
| Carsuzaa, F | 1 |
| Chakma, JK | 2 |
| Girdhar, A | 3 |
| Natrajan, M | 2 |
| Kumar, A | 2 |
| Girdhar, BK | 2 |
| Ezzedine, K | 1 |
| Malvy, D | 1 |
| Beylot, C | 1 |
| Longy-Boursier, M | 1 |
| Manga, NM | 1 |
| Poda, A | 1 |
| Bazolo, N | 1 |
| Sané, O | 1 |
| Batista, G | 1 |
| Guèye, NF | 1 |
| Sow, PS | 1 |
| Badiane, CI | 1 |
| Yuchua-Guillen, A | 1 |
| Dofitas, BL | 1 |
| Malaviya, GN | 2 |
| Hussein, S | 1 |
| Adar, T | 1 |
| Tayer-Shifman, O | 1 |
| Mizrahi, M | 1 |
| Tavdi, S | 1 |
| Barak, O | 1 |
| Shalit, M | 1 |
| Desenfants, A | 1 |
| Huguon, E | 1 |
| Polfrit, Y | 1 |
| Crouzat, M | 1 |
| Rouleau, V | 1 |
| Chassot, V | 1 |
| Besson-Leaud, L | 1 |
| Missotte, I | 1 |
| Gonçalves, Hde S | 1 |
| Pontes, MA | 1 |
| Bührer-Sékula, S | 1 |
| Cruz, R | 1 |
| Almeida, PC | 1 |
| Moraes, ME | 1 |
| Penna, GO | 1 |
| Agrawal, US | 1 |
| Saxena, A | 1 |
| Meena, RS | 1 |
| Saini, M | 1 |
| Saxena, V | 1 |
| Crawford, CL | 1 |
| LANGUILLON, J | 1 |
| ROLLIER, R | 1 |
| CURRIE, G | 1 |
| WATERS, MF | 1 |
| ROSENTHAL, AL | 1 |
| RATHMELL, TK | 1 |
| BROWNE, SG | 1 |
| Alioua, Z | 1 |
| Sbai, M | 1 |
| Elhaouri, M | 1 |
| Bouzidi, A | 1 |
| Boudi, O | 1 |
| Ghfir, M | 1 |
| Benomar, S | 1 |
| Sedrati, OL | 1 |
| Kai, M | 1 |
| Maeda, Y | 1 |
| Maeda, S | 1 |
| Fukutomi, Y | 1 |
| Kobayashi, K | 1 |
| Kashiwabara, Y | 1 |
| Makino, M | 1 |
| Abbasi, MA | 1 |
| Khan, MZ | 1 |
| Shah, PA | 1 |
| Norman, G | 1 |
| Joseph, G | 1 |
| Richard, J | 1 |
| Katoch, K | 3 |
| Katoch, VM | 3 |
| Gupta, UD | 1 |
| Sharma, VD | 2 |
| Shivanavar, CT | 1 |
| Citirik, M | 1 |
| Batman, C | 1 |
| Aslan, O | 1 |
| Adabag, A | 1 |
| Ozalp, S | 1 |
| Zilelioglu, O | 1 |
| Armour, KS | 1 |
| Scolyer, RA | 1 |
| Barnetson, RS | 1 |
| Goulart, IM | 1 |
| Reis, AC | 1 |
| De Rezende, TM | 1 |
| Borges, AS | 1 |
| Ferreira, MS | 1 |
| Nishioka, SA | 1 |
| Salgado, CG | 1 |
| da Silva, JP | 1 |
| da Silva, MB | 1 |
| da Costa, PF | 1 |
| Salgado, UI | 1 |
| Yuen, HK | 1 |
| Liu, DT | 1 |
| Lam, DS | 1 |
| Annigeri, SR | 1 |
| Metgud, SC | 1 |
| Patil, JR | 1 |
| Booth, AV | 1 |
| Kovich, OI | 1 |
| Meyer, M | 1 |
| Ingen-Housz-Oro, S | 1 |
| Ighilahriz, O | 1 |
| Wendling, J | 1 |
| Gaulier, A | 1 |
| Levy-Weil, F | 1 |
| Sigal-Grinberg, M | 1 |
| Flageul, B | 3 |
| Mane, I | 1 |
| Grauwin, MY | 1 |
| Cartel, JL | 2 |
| Chin-a-Lien, RA | 1 |
| Altes-Levy, HR | 1 |
| Naafs, B | 1 |
| Ji, B | 3 |
| Perani, EG | 2 |
| Petinom, C | 1 |
| N'Deli, L | 1 |
| Grosset, JH | 3 |
| Jamet, P | 3 |
| Blanc, L | 1 |
| Fayne, OC | 1 |
| Traore, I | 2 |
| Bobin, P | 1 |
| Habte-Mariam, HS | 1 |
| Guebre-Xabier, M | 1 |
| Mendis, S | 1 |
| Somasiri, KG | 1 |
| Chularatna, W | 1 |
| Honoré, N | 1 |
| Perrani, E | 1 |
| Telenti, A | 1 |
| Grosset, J | 1 |
| Cole, ST | 1 |
| Grossman, D | 1 |
| Rapini, RP | 1 |
| Osborne, B | 1 |
| Duvic, M | 1 |
| Drowart, A | 1 |
| Chanteau, S | 1 |
| Huygen, K | 1 |
| De Cock, M | 1 |
| De Bruyn, J | 1 |
| Launois, P | 2 |
| Yernault, JC | 1 |
| Van Vooren, JP | 1 |
| Roche, PW | 3 |
| Britton, WJ | 2 |
| Failbus, SS | 2 |
| Neupane, KD | 2 |
| Theuvenet, WJ | 2 |
| Chauhan, SL | 1 |
| Husain, S | 1 |
| Mukherjee, A | 1 |
| Blum, L | 1 |
| Sow, S | 2 |
| Vignon-Pennamen, MD | 1 |
| Coll, A | 1 |
| Millan, J | 1 |
| Hortaleza, AR | 1 |
| Salta-Ramos, NG | 1 |
| Barcelona-Tan, J | 1 |
| Abad-Venida, L | 1 |
| Thompson, K | 2 |
| Sampaio, EP | 2 |
| Malta, AM | 1 |
| Kaplan, G | 1 |
| Job, CK | 1 |
| Rao, PS | 1 |
| Ramachandran, A | 1 |
| Sekar, B | 1 |
| Ravi, S | 1 |
| Subramanian, M | 1 |
| Cambau, E | 1 |
| Perani, E | 1 |
| Guillemin, I | 1 |
| Shetty, VP | 1 |
| Uplekar, MW | 1 |
| Antia, NH | 1 |
| de Carsalade, GY | 1 |
| Wallach, D | 1 |
| Spindler, E | 1 |
| Pennec, J | 1 |
| Cottenot, F | 1 |
| Celik, O | 1 |
| Yalcin, S | 1 |
| Gok, U | 1 |
| Yavrucuoglu, E | 1 |
| Ozturk, A | 1 |
| Akyol, A | 1 |
| Velázquez de Castro y Sagarra, A | 1 |
| López Bueno, R | 1 |
| Gómez Jiménez, G | 1 |
| Ganapati, R | 1 |
| Pai, VV | 1 |
| Banerji, U | 1 |
| Thomas, J | 1 |
| Saha, B | 1 |
| Gálvez, J | 1 |
| López-Domínguez, JM | 1 |
| Navarro, A | 1 |
| Creagh, R | 1 |
| Casado, JL | 1 |
| Chinchón Lara, I | 1 |
| Arunthathi, S | 1 |
| Raju, S | 1 |
| Mitra, S | 1 |
| Gombar, KK | 1 |
| Gombar, S | 1 |
| Kabra, NS | 1 |
| Nanavati, RN | 1 |
| Srinivasan, G | 1 |
| Ong, AK | 1 |
| Frankel, RI | 1 |
| Maruyama, MH | 1 |
| Krishna, KK | 1 |
| Manandhar, R | 1 |
| LeMaster, JW | 1 |
| Boisseau-Garsaud, AM | 1 |
| Vezon, G | 1 |
| Helenon, R | 1 |
| Garsaud, P | 1 |
| Saint-Cyr, I | 1 |
| Quist, D | 1 |
| Shaw, IN | 1 |
| Ebenezer, G | 1 |
| Rao, GS | 1 |
| Natrajan, MM | 1 |
| Balasundaram, B | 1 |
| Baxt, RD | 1 |
| Ramos-e-Silva, M | 1 |
| Rebello, PF | 1 |
| Petering, H | 1 |
| Kiehl, P | 1 |
| Vogelbruch, M | 1 |
| Sticht-Groh, V | 1 |
| Kapp, A | 1 |
| Werfel, T | 1 |
| Prince, JM | 1 |
| Janner, D | 1 |
| Rea, TH | 1 |
| Reeve, PA | 1 |
| Ala, J | 1 |
| Hall, JJ | 1 |
| Becx-Bleumink, M | 2 |
| Lalwani, AK | 1 |
| Tami, TA | 1 |
| Gelber, RH | 1 |
| Sehgal, VN | 1 |
| Chaudary, AK | 1 |
| Mahajan, DM | 1 |
| Bedi, BS | 1 |
| Cho, SN | 1 |
| Graninger, W | 1 |
| Hollenstein, U | 1 |
| Dudeck, U | 1 |
| Kremsner, PG | 1 |
| Saylan, T | 1 |
| Constant-Desportes, M | 1 |
| Guelpa-Lauras, CC | 1 |
| Carolina, JC | 1 |
| Léoture, A | 1 |
| Sansarricq, H | 1 |
| Natarajan, M | 1 |
| Bagga, A | 1 |
| Cellona, RV | 3 |
| Fajardo, TT | 3 |
| Kim, DI | 1 |
| Hah, YM | 1 |
| Ramasoota, T | 1 |
| Sampattavanich, S | 1 |
| Carrillo, MP | 1 |
| Abalos, RM | 3 |
| dela Cruz, EC | 1 |
| Ito, T | 1 |
| Gill, HK | 1 |
| Ridley, DS | 1 |
| Ganesan, J | 1 |
| Mustafa, AS | 1 |
| Rees, RJ | 1 |
| Godal, T | 1 |
| Thomas, A | 2 |
| Balakrishnan, A | 1 |
| Nagarajan, M | 2 |
| Prabhakar, R | 2 |
| Tripathy, SP | 1 |
| Christian, M | 2 |
| Somasundaram, PR | 2 |
| Esquenazi, DA | 1 |
| Moreira, AL | 1 |
| Gallo, ME | 1 |
| Almeida, SM | 1 |
| Janniger, CK | 1 |
| Kapila, R | 1 |
| Schwartz, RA | 1 |
| Levis, WR | 1 |
| Lambert, WC | 1 |
| Li, W | 1 |
| Ye, G | 1 |
| Yang, Z | 1 |
| Tao, M | 1 |
| Luo, J | 1 |
| Wang, C | 1 |
| Ji, F | 1 |
| Patki, AH | 2 |
| Mehta, JM | 1 |
| Girdhar, M | 1 |
| Arora, SK | 1 |
| Mohan, L | 1 |
| Mukhija, RD | 1 |
| Kulkarni, V | 1 |
| Gharpuray, MB | 1 |
| Kulkarni, DS | 1 |
| Douglas, JT | 2 |
| Hirsch, DS | 2 |
| de la Cruz, EC | 2 |
| Madarang, MG | 2 |
| de Wit, MY | 2 |
| Klatser, PR | 2 |
| Ramu, G | 2 |
| Ramanathan, U | 1 |
| Sengupta, U | 1 |
| Shivannavar, CT | 1 |
| Pritze, S | 1 |
| Alvarenga, AE | 1 |
| Leguizamon, O | 1 |
| Haubitz, I | 1 |
| Chatterjee, G | 1 |
| Kaur, S | 4 |
| Sharma, VK | 2 |
| Vaishnavi, C | 3 |
| Ganguly, NK | 3 |
| Suster, S | 1 |
| Cabello-Inchausti, B | 1 |
| Robinson, MJ | 1 |
| Thakur, M | 1 |
| Kumar, B | 2 |
| Balakrishnan, S | 1 |
| Karthikeyan, S | 1 |
| Pavithran, K | 1 |
| Li, HY | 1 |
| Yu, XL | 1 |
| Zhang, MS | 1 |
| Duan, CX | 1 |
| Huang, WB | 1 |
| Zhang, SB | 1 |
| Zhu, K | 1 |
| Ma, JF | 1 |
| Ekambaram, V | 1 |
| Rao, MK | 1 |
| Aschhoff, M | 1 |
| Raj, PP | 1 |
| Lilly, L | 1 |
| Srinivasan, H | 1 |
| Chandrasekaran, V | 1 |
| Hari, L | 1 |
| Bhatia, VN | 1 |
| Roy, RG | 1 |
| Anilkumar, G | 1 |
| Sonvane, MV | 1 |
| Nampalle, VB | 1 |
| Nathani, PJ | 1 |
| Ellard, GA | 2 |
| Pannikar, VK | 1 |
| Jesudasan, K | 1 |
| Garg, SK | 1 |
| Bakaya, V | 1 |
| Lal, R | 1 |
| Shukla, VK | 1 |
| Kiran, KU | 1 |
| Stanley, JN | 1 |
| Kaur, H | 1 |
| Chaudhury, S | 1 |
| Hazra, S | 1 |
| Podder, GC | 1 |
| Poddar, S | 1 |
| Sarkar, S | 1 |
| Das, PK | 1 |
| Chaudhury, SN | 1 |
| Majumder, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Independent Study to Establish the Efficacy of the Six Doses Uniform MDT Regimen (U-MDT) for Leprosy Patients[NCT00669643] | Phase 4 | 859 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for dapsone and Leprosy, Cutaneous
| Article | Year |
|---|---|
Chronic Unilateral Uveitis as a Manifestation of Leprosy: A Case Report and Literature Review.
Topics: Aged; Atrophy; Biopsy; Chronic Disease; Clofazimine; Dapsone; Drug Therapy, Combination; Eye Infecti | 2021 |
Leprosy - an overview of clinical features, diagnosis, and treatment.
Topics: Adult; Aged; Child; Clofazimine; Cross-Sectional Studies; Dapsone; Disease Progression; Drug Adminis | 2017 |
Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Topics: Adult; Breast Feeding; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic | 2017 |
Dapsone-induced photosensitivity: a rare clinical presentation.
Topics: Adult; Dapsone; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Photosensitivity Diso | 2008 |
[Histoid leprosy with erythema nodosum leprosum].
Topics: Adult; Clofazimine; Dapsone; Erythema Nodosum; Fluoroquinolones; Histiocytes; Humans; Leprostatic Ag | 2003 |
Leprosy. Recognition and treatment.
Topics: Adolescent; Adult; Age Factors; Biopsy; Child; Clinical Trials as Topic; Clofazimine; Dapsone; Diagn | 2001 |
Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational proced
Topics: Clofazimine; Dapsone; Epidemiologic Methods; Ethiopia; Humans; Incidence; Leprostatic Agents; Lepros | 1992 |
Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Topics: Dapsone; Drug Therapy, Combination; Ethiopia; Humans; Leprosy; Leprosy, Borderline; Leprosy, Leproma | 1992 |
13 trials available for dapsone and Leprosy, Cutaneous
| Article | Year |
|---|---|
Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic | 2012 |
Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
Topics: Acedapsone; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans | 2004 |
10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; BCG Vaccine; Biological Assay; Clofazimine; Comb | 2004 |
Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.
Topics: Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Foot; Humans; L | 1994 |
Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Humans; Interferon-gamma; Leprost | 1996 |
Ofloxacin-containing combined drug regimens in the treatment of lepromatous leprosy.
Topics: Adult; Animals; Anti-Infective Agents; Biopsy, Needle; Clofazimine; Dapsone; Drug Therapy, Combinati | 1994 |
Daily multidrug therapy for leprosy; results of a fourteen-year experience.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Resistance, Microbial; | 1997 |
High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Fema | 1997 |
A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Erythema; Humans; Interferon Type I; Lepromin; Lepr | 1997 |
Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Dapsone; Double-Blind Method; Drug Combin | 1992 |
Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines, and Korea.
Topics: Adolescent; Adult; Animals; Biopsy; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; | 1990 |
Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant, Newborn; | 1990 |
A double-blind controlled clinical trial to assess the role of anti-histamines in the treatment of multi-bacillary leprosy.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clofazimine; Dapsone; Double-Blind Method; Drug T | 1988 |
107 other studies available for dapsone and Leprosy, Cutaneous
| Article | Year |
|---|---|
Hematological alterations in lepromatous leprosy: A cross-sectional observational study.
Topics: Adult; Case-Control Studies; Cross-Sectional Studies; Dapsone; Erythrocyte Indices; Female; Hematocr | 2020 |
The Clinical Trend of Leprosy from 2000 to 2016 in Kaohsiung, a Major International Harbor City in Taiwan, Where Leprosy is Almost Eradicated.
Topics: Adult; Aged; Dapsone; Disease Eradication; Female; Humans; Leprosy; Leprosy, Lepromatous; Male; Midd | 2021 |
Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
Topics: Clofazimine; Dapsone; Disease Progression; Drug Therapy, Combination; Erythema Nodosum; Humans; Lepr | 2020 |
Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brazil; Child; Child, Preschool; Clofazimine; Dapsone; D | 2021 |
Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction.
Topics: Adult; Anemia, Hemolytic; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Le | 2021 |
Multiple livid-erythematous macules and plaques with slight scaling in a young man.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Erythema; Humans; Lep | 2018 |
Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release.
Topics: Antifungal Agents; Brazil; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromato | 2018 |
[Histoid leprosy].
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Granuloma; Guinea; Histiocytes; Humans; Lepr | 2013 |
A case of Hansen Disease presenting as tinea versicolor.
Topics: Clofazimine; Contraindications; Dapsone; Delayed Diagnosis; Diagnostic Errors; Humans; Hypesthesia; | 2013 |
Leprosy in pregnant woman, United States.
Topics: Adult; Cesarean Section, Repeat; Dapsone; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; | 2013 |
T-cell plasticity of dapsone and DRESS.
Topics: Adult; Dapsone; Drug Hypersensitivity Syndrome; Female; Humans; Leprostatic Agents; Leprosy, Leproma | 2014 |
[Borderline lepromatous leprosy].
Topics: Adult; Biopsy; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy, Borderline; | 2014 |
A man with facial changes.
Topics: Clofazimine; Dapsone; Facies; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium | 2014 |
Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
Topics: Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; M | 2015 |
Diffuse Lepromatous Leprosy Due to Mycobacterium lepromatosis in Quintana Roo, Mexico.
Topics: Adult; Base Sequence; Clofazimine; Dapsone; DNA, Bacterial; Drug Combinations; Female; Humans; Lepro | 2015 |
Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
Topics: Adult; Dapsone; Drug Hypersensitivity; Eosinophilia; Humans; Leprostatic Agents; Leprosy, Lepromatou | 2015 |
Leproma Presenting as a Nasal Cavity Mass.
Topics: Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Endoscopy; Female; Follow-Up Studies; Humans; | 2015 |
Wade histoid leprosy revisited.
Topics: Adolescent; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Le | 2016 |
[Lepromatous leprosy revealed by a swollen hands syndrome].
Topics: Adult; Anti-Bacterial Agents; Dapsone; Edema; Hand Injuries; Humans; Leprosy, Lepromatous; Male; Myc | 2009 |
Two microbiological relapses in a patient with lepromatous leprosy.
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Lepros | 2008 |
Autochthonous leprosy in metropolitan France presenting with a diffuse infiltration of the face and febrile illness.
Topics: Biopsy, Needle; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Facial Der | 2009 |
[Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Dapsone; Diagnostic Errors; Female; HIV Infections; | 2011 |
Atypical Hansen's disease presenting as florid verrucous plaques on the lower extremities: a case report.
Topics: Biopsy; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Glucocorticoids; Humans; | 2012 |
Florid reactive periostitis ossificans of long bones and digits associated with reaction in a patient with leprosy.
Topics: Adolescent; Clofazimine; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous | 2012 |
Dapsone induced eosinophilic pneumonia.
Topics: Aged; Biopsy; Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Pulmonar | 2012 |
[Leprosy with an unusual course].
Topics: Anemia, Hemolytic; Child; Dapsone; Disease Progression; Drug Therapy, Combination; Erythema Nodosum; | 2012 |
Hansen's disease mimicking palmoplantar keratoderma.
Topics: Child; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Keratoderma | 2002 |
The schizophrenic career of a "monster drug".
Topics: Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy; Leprosy, Lepromatous; Nervous System | 2003 |
[Results of the treatment of 15 cases of lepromatous leprosy with 4-4'-diaminodiphenylsulfone].
Topics: Dapsone; Leprosy; Leprosy, Lepromatous; Sulfones | 1951 |
[Combination of red sarsaparilla & 4,4'-diaminodiphenylsulfone in therapy of lepromatous leprosy; study of 73 cases].
Topics: Biological Products; Dapsone; Leprosy; Leprosy, Lepromatous; Saponins; Smilax; Sulfones | 1957 |
A clinical trial of etisul in lepromatous leprosy.
Topics: Dapsone; Humans; Leprosy; Leprosy, Lepromatous | 1963 |
CHEMOTHERAPEUTIC TRIALS IN LEPROSY. 1. COMPARATIVE TRIAL OF MACROCYCLON PLUS DAPSONE AND DAPSONE ALONE IN THE TREATMENT OF LEPROMATOUS LEPROSY.
Topics: Dapsone; Humans; Leprosy; Leprosy, Lepromatous; Polyethylene Glycols | 1963 |
LEPROMATOUS HANSEN'S DISEASE.
Topics: Communicable Disease Control; Dapsone; Humans; Leprosy; Leprosy, Lepromatous; Sulfones; Toxicology | 1964 |
A VARICELLIFORM ERUPTION APPEARING IN THE COURSE OF ACUTE EXACERBATION OF LEPROMATOUS LEPROSY.
Topics: Dapsone; Drug Therapy; Humans; Leprosy; Leprosy, Lepromatous; Microbiology; Skin Manifestations | 1965 |
Active surveillance of leprosy contacts in country with low prevalence rate.
Topics: Adult; Antibodies, Bacterial; Antigens, Bacterial; Child; Dapsone; DNA-Directed RNA Polymerases; Dru | 2004 |
Lepromatous iridocyclitis.
Topics: Adult; Aqueous Humor; Dapsone; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glucoco | 2005 |
Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Forearm; Glucocorticoi | 2005 |
Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
Topics: Adult; Anemia, Aplastic; Brazil; Clofazimine; Dapsone; Disease Progression; Drug Therapy, Combinatio | 2005 |
Cutaneous diffuse chromoblastomycosis.
Topics: Adult; Chromoblastomycosis; Dapsone; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male | 2005 |
Corneal leproma as an initial feature of lepromatous leprosy.
Topics: Aged; Corneal Diseases; Dapsone; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Human | 2006 |
Lepromatous leprosy of histoid type.
Topics: Adult; Dapsone; Drug Resistance, Bacterial; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous | 2007 |
Lepromatous leprosy.
Topics: Biopsy; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Huma | 2007 |
[Polyarthritis and papular eruption revealing leprosy].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Arthritis; Biopsy; Clofazimine; Dapsone; Drug | 2008 |
[The frequency of the appearance of perforating foot ulcers in patients with Hansen's disease as a function of treatment with disulone alone or with polychemotherapy].
Topics: Chronic Disease; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Foot Ulcer; Humans; Leprosta | 1995 |
Midborderline (BB)-borderline lepromatous (BL) leprosy with reversal reaction (RR).
Topics: Aged; Biopsy; Clofazimine; Cyclosporine; Dapsone; Diabetes Complications; Humans; Leprosy, Lepromato | 1994 |
Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
Topics: Adult; Aged; Confidence Intervals; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; | 1994 |
Loss of viability of Mycobacterium leprae isolated from nasal secretions of lepromatous leprosy patients following daily rifampicin and DDS therapy.
Topics: Animals; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Lepromatous; Mice; Mice, Inbred BALB C | 1993 |
Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Electrophysiology; | 1993 |
A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae.
Topics: Alleles; Amino Acid Sequence; Base Sequence; Dapsone; DNA Primers; DNA-Directed RNA Polymerases; DNA | 1993 |
Emergence of leprosy in a patient with mycosis fungoides.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dapsone; Humans; Leprosy, | 1994 |
Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Glycoli | 1993 |
Serological monitoring of the response to chemotherapy in leprosy patients.
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Antigens, Bacterial; Child; Dapsone; Drug Resistance | 1993 |
Borderline-tuberculoid relapse in lepromatous leprosy.
Topics: Dapsone; Female; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Midd | 1993 |
Leprosy reversal reaction in HIV-positive patients.
Topics: Adult; Anti-Bacterial Agents; Blotting, Western; Dapsone; Enzyme-Linked Immunosorbent Assay; HIV Ser | 1993 |
Dapsone syndrome in a Filipino man.
Topics: Adolescent; Dapsone; Drug Hypersensitivity; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; | 1995 |
An unusual presentation of facial palsy in leprosy; a case report.
Topics: Aged; Dapsone; Facial Paralysis; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromato | 1995 |
Silent iritis in treated bacillary negative leprosy.
Topics: Aged; Dapsone; Drug Therapy, Combination; Female; Humans; Iritis; Leprostatic Agents; Leprosy, Borde | 1996 |
Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; | 1997 |
Primary resistance to single and multiple drugs in leprosy--a mouse footpad study.
Topics: Adult; Animals; Armadillos; Clofazimine; Dapsone; Drug Resistance, Microbial; Female; Humans; Lepros | 1996 |
Auditory brain stem evoked potentials in patients with leprosy.
Topics: Adult; Auditory Diseases, Central; Dapsone; Evoked Potentials, Auditory, Brain Stem; Humans; Leprost | 1997 |
[Suspected leprosy].
Topics: Adult; Aged; Aged, 80 and over; Dapsone; Diagnosis, Differential; Female; Humans; Leprostatic Agents | 1997 |
[Patient with Hansen disease and lepromatous reaction with predominant neural involvement].
Topics: Biopsy; Clofazimine; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Ma | 1998 |
Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
Topics: Dapsone; Diagnosis, Differential; Eosinophils; Humans; Leprostatic Agents; Leprosy, Lepromatous; Leu | 1998 |
Anaesthetic considerations in a patient with lepromatous leprosy.
Topics: Adjuvants, Anesthesia; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Atrac | 1998 |
Neonatal methemoglobinemia due to transplacental transfer of dapsone.
Topics: Dapsone; Diagnosis, Differential; Female; Humans; Infant, Newborn; Leprostatic Agents; Leprosy, Lepr | 1998 |
Cluster of leprosy cases in Kona, Hawaii; impact of the Compact of Free Association.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Contact Tracing; Cultural Depriva | 1999 |
Histoid leprosy; report of three cases.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, | 1999 |
Risk factors for erythema nodosum leprosum.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Clofazimine; Cohor | 1999 |
High prevalence of vitiligo in lepromatous leprosy.
Topics: Adult; Aged; Aged, 80 and over; Clofazimine; Dapsone; Female; Humans; Leprostatic Agents; Leprosy, L | 2000 |
Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Topics: Acedapsone; Adolescent; Adult; Animals; Child; Clofazimine; Dapsone; Drug Resistance, Microbial; Dru | 2000 |
Lepromatous leprosy with drug reaction.
Topics: Clofazimine; Dapsone; Drug Eruptions; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy | 2000 |
[Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
Topics: Adult; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Erythema Nodosum; Follow-Up Studies; | 2001 |
Nodular rash in an Indonesian girl.
Topics: Adolescent; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans | 2001 |
Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy.
Topics: Anemia; Dapsone; Erythema Nodosum; Hemoglobins; Humans; Leprostatic Agents; Leprosy, Lepromatous; Pr | 2001 |
Modification of multidrug treatment of leprosy in Vanuatu.
Topics: Aged; Dapsone; Drug Combinations; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy, Lepromat | 1992 |
Lepromatous leprosy: nasal manifestations and treatment with minocycline.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Lepromatous; Male; Minocycline; Nose Dis | 1992 |
Type II (ENL) reaction in histoid leprosy in a child.
Topics: Adolescent; Dapsone; Erythema Nodosum; Humans; Leprosy, Lepromatous; Male | 1991 |
The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Carbohydrate Sequence; Clofazimine; Dapsone; Drug Therap | 1991 |
[Autoantibodies in lepromatous leprosy].
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Antigen-Antibody Complex; Autoantibodies; Child; D | 1991 |
A case of relapse with drug-susceptible M. leprae after multidrug therapy.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Male; | 1991 |
Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Lep | 1991 |
Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged dapsone chemotherapy.
Topics: Antigens, Bacterial; Clone Cells; Dapsone; Humans; Leprosy, Lepromatous; Lymphocyte Activation; Myco | 1990 |
Effect of treatment on immune responsiveness in lepromatous leprosy patients.
Topics: Dapsone; Humans; Lepromin; Leprosy, Lepromatous; Lymphocyte Activation; Skin Tests | 1990 |
Histoid lepromas of lepromatous leprosy.
Topics: Dapsone; Drug Resistance; Histiocytes; Humans; Leprosy, Lepromatous; Male; Middle Aged; Skin; United | 1990 |
Effect of three-year multidrug therapy in multibacillary leprosy patients.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy, Borderline | 1990 |
Dapsone-induced erythroderma with Beau's lines.
Topics: Adult; Dapsone; Dermatitis, Exfoliative; Female; Humans; Leprosy, Lepromatous; Nails, Malformed | 1989 |
Pattern of leprosy disabilities in Gorakhpur (Uttar Pradesh).
Topics: Adolescent; Adult; Age Factors; Aged; Child; Dapsone; Disabled Persons; Female; Humans; India; Lepro | 1989 |
Multiple cold abscesses in a borderline lepromatous patient on multidrug therapy.
Topics: Abscess; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Ethambutol; Hip Joint; Humans; Ison | 1989 |
Evaluation of Mycobacterium leprae antigens in the serological monitoring of a clofazimine-based chemotherapeutic study of dapsone resistant lepromatous leprosy patients in Cebu, Philippines.
Topics: Adult; Antigens, Bacterial; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbia | 1989 |
Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; | 1989 |
Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Lepros | 1989 |
Evaluation of Mycobacterium leprae antigens in the monitoring of a dapsone-based chemotherapy of previously untreated lepromatous patients in Cebu, Philippines.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Dapsone; Enzyme-Linked Immunosorbent Assay; Humans; Lepr | 1989 |
Bacillaemia in leprosy and effect of multidrug therapy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy | 1989 |
Nongranulomatous involvement of the bone marrow in lepromatous leprosy.
Topics: Adult; Aged; Bone Marrow; Bone Marrow Examination; Carrier State; Dapsone; Eosinophils; Humans; Lepr | 1989 |
Primary dapsone resistance as assessed by uptake of labelled thymidine by the macrophage resident Mycobacterium leprae.
Topics: Cells, Cultured; Dapsone; Drug Resistance, Microbial; Humans; Leprosy, Lepromatous; Macrophages; Myc | 1989 |
Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
Topics: Adolescent; Adult; Bilirubin; Body Weight; Child; Dapsone; Drug Administration Schedule; Erythrocyte | 1989 |
Vitiligo following type II lepra reaction.
Topics: Autoimmune Diseases; Clofazimine; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Lep | 1989 |
Dapsone and erythema nodosum leprosum.
Topics: Dapsone; Erythema Nodosum; Humans; Leprosy, Lepromatous | 1989 |
Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
Topics: Adult; China; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; L | 1989 |
Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
Topics: Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; India; L | 1989 |
Secondary and primary dapsone resistant leprosy: an analysis of 199 patients from St. Thomas Hospital and leprosy project, Chettupattu, South India.
Topics: Age Factors; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy, Lepromatous; Male; Mycoba | 1988 |
Tetanus in patient with lepromatous leprosy (I).
Topics: Adult; Dapsone; Foot Diseases; Humans; Leprosy, Lepromatous; Male; Seizures; Skin Ulcer; Tetanus | 1988 |
Clofazimine and dapsone compliance in leprosy.
Topics: Clofazimine; Dapsone; Humans; Leprosy, Lepromatous; Patient Compliance; Pilot Projects; Rifampin; Se | 1988 |
Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients.
Topics: Adult; Chromatography, High Pressure Liquid; Dapsone; Humans; Leprosy, Lepromatous; Middle Aged | 1988 |
Long-term prothionamide compliance: a study carried out in India using a combined formulation containing prothionamide, dapsone and isoniazid.
Topics: Adolescent; Adult; Dapsone; Drug Therapy, Combination; Female; Humans; India; Isoniazid; Isonicotini | 1988 |
Effect of multidrug therapy on the levels of antibodies to Mycobacterium leprae glycolipid-1 in the leprosy spectrum.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Glycoli | 1988 |
New multidrug regimen with indigenous drugs and dapsone in the treatment of lepromatous leprosy (preliminary report).
Topics: Animals; Anti-Infective Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Fatty Acids; Humans | 1987 |